COMMUNIQUÉS West-GlobeNewswire

-
Conditional Issuance of Shares
16/04/2025 -
Émission Conditionnelle d’Actions
16/04/2025 -
Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025
16/04/2025 -
Santhera shares updates on commercial rollout of AGAMREE®
16/04/2025 -
Higher cantonal composition authority approved the amendments to the terms of the 2025 convertible bond
16/04/2025 -
Ipsen delivers strong sales in the first quarter 2025 and confirms its full-year guidance
16/04/2025 -
Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l’exercice 2025
16/04/2025 -
Automated Health Systems Expands Access to Public Healthcare Nationwide with Smarter Solutions
16/04/2025 -
Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
16/04/2025 -
Raw Garden Launches Blockbuster Deals for 4/20 Across California
16/04/2025 -
IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
16/04/2025 -
Fatima Rifai Expands Functional Diet Supplement Business Amid Lebanon’s Economic Crisis
16/04/2025 -
Theratechnologies Provides Update on Sale Process
16/04/2025 -
Theratechnologies fait le point sur le processus de vente
16/04/2025 -
Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targeted ADC for Hematologic and Solid Malignancies
15/04/2025 -
Ascension Seton to Take Full Ownership of Cedar Park Medical Center, Strengthening Patient-Centered Care
15/04/2025 -
Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer
15/04/2025 -
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
15/04/2025 -
Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
15/04/2025
Pages